Opiant Pharmaceuticals jumped nearly 30% yesterday on a favorable report from Zachs, making it the forth largest position in Todd Hagopian's Biotech Fund. Here's what Todd thinks of the news.
from Forbes Real Time https://www.forbes.com/sites/kenkam/2017/09/20/opiant-up-nearly-30-on-favorable-zachs-report/
via IFTTT
No comments:
Post a Comment